February 8, 2023 (Investorideas.com Newswire) Pharmaceutical powerhouse Awakn has been awarded Innovative Licensing and Access Pathway (ILAP) access to UK markets.
What's your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0